And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest this time around. We plan to indulge a couple of the short people, visit the Pharmalot ancestors, and promenade with our official mascot. And what about you? Summer is now officially here, so the time has come to enjoy the great outdoors and plan a getaway, if you can get away. You could also hit the proverbial pause button and catch up with someone special or plan the rest of your life. For the mischievous among you, perhaps you want to place bets on whether a certain someone will change his mind again and escalate tensions in a well-known hot spot. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. ..

Merck (MRK) chief executive Ken Frazier predicted there will be “legal challenges” if the Trump administration proceeds with plans to institute an International Pricing Index, which would cap what Medicare pays for certain medicines based on prices charged in other countries. “A lot of people have objections to that rule. It’s not just pharmaceutical companies,” he told journalists following a briefing for investors. He also referred to the idea as “price controls.” Earlier this week, Sen. Chuck Grassley indicated he would not support the idea.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy